Breaking Study Supports Noninvasive Central Blood Pressure As A Treatment Target
Nov 21st 2008Drug InformationHypertension
AtCor Medical (ASX: ACG), the developer and marketer of the SphygmoCor(R) system, which measures central blood pressures and arterial stiffness noninvasively, today announced that a new study* funded by the National Institutes of Health (NIH) found that when patients’ central pulse pressures exceeded 50 mm of mercury, there was a significant increase in cardiovascular events.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
